Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

Rationale for routine use of IORT for early breast cancer and data for specific indications

The role of technology in value-based care

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer

Lisocabtagene maraleucel is efficacious at treating R/R chronic lymphocytic leukaemia/small lymphocytic lymphoma

ASCO 2023: Lung cancer research highlights

Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment

FOLFOX with selective use of 5FUCRT is non-inferior to 5FUCRT for treatment of LARC prior to low anterior resection with TME

Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma